Literature DB >> 20519243

Functional analysis of novel TBX5 T-box mutations associated with Holt-Oram syndrome.

Cornelis J J Boogerd1, Dennis Dooijes, Aho Ilgun, Inge B Mathijssen, Roel Hordijk, Ingrid M B H van de Laar, Patrick Rump, Hermine E Veenstra-Knol, Antoon F M Moorman, Phil Barnett, Alex V Postma.   

Abstract

AIMS: Holt-Oram syndrome (HOS) is a heart/hand syndrome clinically characterized by upper limb and cardiac malformations. Mutations in T-box transcription factor 5 (TBX5) underlie this syndrome, the majority of which lead to premature stops. In this study, we present our functional analyses of five (novel) missense TBX5 mutations identified in HOS patients, most of whom presented with severe cardiac malformations. METHODS AND
RESULTS: Functional characterization of mutant proteins shows a dramatic loss of DNA-binding capacity, as well as diminished binding to known cardiac interaction partners NKX2-5 and GATA4. The disturbance of these interactions leads to a loss of function, as measured by the reduced activation of Nppa and FGF10 in rat heart derived cells, although with variable severity. Two out of the five mutations are peculiar: one, p.H220del, is associated with additional extra-cardiac defects, perhaps by interfering with other T-box dependant pathways, and another, p.I106V, leads to limb defects only, which is supported by its normal interaction with cardiac-specific interaction partners.
CONCLUSION: Overall, our data are consistent with the hypothesis that these novel missense mutations in TBX5 lead to functional haploinsufficiency and result in a reduced transcriptional activation of target genes, which is likely central to the pathogenesis of HOS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519243     DOI: 10.1093/cvr/cvq178

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.

Authors:  Clémence Vanlerberghe; Anne-Sophie Jourdain; Jamal Ghoumid; Frédéric Frenois; Aurélie Mezel; Guy Vaksmann; Bruno Lenne; Bruno Delobel; Nicole Porchet; Valérie Cormier-Daire; Thomas Smol; Fabienne Escande; Sylvie Manouvrier-Hanu; Florence Petit
Journal:  Eur J Hum Genet       Date:  2018-12-14       Impact factor: 4.246

2.  Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.

Authors:  Débora Varela; Tatiana Varela; Natércia Conceição; Ângela Ferreira; Nuno Marques; Ana Paula Silva; Pedro Azevedo; Salomé Pereira; Ana Camacho; Ilídio de Jesus; M Leonor Cancela
Journal:  Mol Genet Genomics       Date:  2021-04-17       Impact factor: 3.291

3.  miR-10a and miR-10b target the 3'-untranslated region of TBX5 to repress its expression.

Authors:  Feng Wang; Xue-Yan Yang; Jian-Yuan Zhao; Li-Wei Yu; Ping Zhang; Wen-Yuan Duan; Mei Chong; Yong-Hao Gui
Journal:  Pediatr Cardiol       Date:  2014-04-09       Impact factor: 1.655

Review 4.  TBX5: A Key Regulator of Heart Development.

Authors:  J D Steimle; I P Moskowitz
Journal:  Curr Top Dev Biol       Date:  2016-09-28       Impact factor: 4.897

Review 5.  The role of transcription factors in atrial fibrillation.

Authors:  Mengchen Zhou; Yuhua Liao; Xin Tu
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

6.  A novel missense mutation in the TBX5 gene in a Saudi infant with Holt-Oram syndrome.

Authors:  Mohammad M Al-Qattan; Hussam Abou Al-Shaar
Journal:  Saudi Med J       Date:  2015-08       Impact factor: 1.484

7.  Genetic mutation analysis in Japanese patients with non-syndromic congenital heart disease.

Authors:  Akiko Yoshida; Hiroko Morisaki; Mai Nakaji; Masataka Kitano; Ki-Sung Kim; Koichi Sagawa; Shiro Ishikawa; Ichiro Satokata; Yoshihide Mitani; Hitoshi Kato; Kenji Hamaoka; Shigeyuki Echigo; Isao Shiraishi; Takayuki Morisaki
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

8.  Induction of apoptosis and inhibition of cell growth by tbx5 knockdown contribute to dysmorphogenesis in Zebrafish embryos.

Authors:  Jenher Lu; Tzuchun Tsai; Sielin Choo; Shuyu Yeh; Renbing Tang; Anhang Yang; Hsinyu Lee; Jennkan Lu
Journal:  J Biomed Sci       Date:  2011-10-08       Impact factor: 8.410

9.  Mutational screening of affected cardiac tissues and peripheral blood cells identified novel somatic mutations in GATA4 in patients with ventricular septal defect.

Authors:  Chunyan Cheng; Yuan Lin; Fan Yang; Wenjing Wang; Chong Wu; Jingli Qin; Xiuqin Shao; Lei Zhou
Journal:  J Biomed Res       Date:  2011-11

10.  Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.

Authors:  Franziska S Rathjens; Alica Blenkle; Lavanya M Iyer; Anke Renger; Fahima Syeda; Claudia Noack; Andreas Jungmann; Matthias Dewenter; Karl Toischer; Ali El-Armouche; Oliver J Müller; Larissa Fabritz; Wolfram-Hubertus Zimmermann; Laura C Zelarayan; Maria-Patapia Zafeiriou
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.